Literature DB >> 10588096

Correlation between MR and clinical findings of disease activity in multiple sclerosis.

H F McFarland.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10588096      PMCID: PMC7657790     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  5 in total

Review 1.  Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

Authors:  P D Molyneux; M Filippi; F Barkhof; C Gasperini; T A Yousry; L Truyen; H M Lai; M A Rocca; I F Moseley; D H Miller
Journal:  Ann Neurol       Date:  1998-03       Impact factor: 10.422

2.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

Authors:  J I O'Riordan; A J Thompson; D P Kingsley; D G MacManus; B E Kendall; P Rudge; W I McDonald; D H Miller
Journal:  Brain       Date:  1998-03       Impact factor: 13.501

3.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

Review 4.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis.

Authors:  D H Miller; R I Grossman; S C Reingold; H F McFarland
Journal:  Brain       Date:  1998-01       Impact factor: 13.501

5.  Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.

Authors:  M E Smith; L A Stone; P S Albert; J A Frank; R Martin; M Armstrong; H Maloni; D E McFarlin; H F McFarland
Journal:  Ann Neurol       Date:  1993-05       Impact factor: 10.422

  5 in total
  1 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.